Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		High dose erlotinib for recurrent/residual GBM; Correlation of response to EGFRvIII and PTEN status

		Keywords:		erlotinib

		Phase:		Phase 1/2

		Treatment ID#s:		VT1834

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		11/08/2007

		Tumor Types:		Any Malignant Brain Tumor Glioblastoma Multiforme


		Comments:

		Treatment Type:		Surgery Chemotherapy.

		Contact:		Weill Cornell Medical College John Boockvar, MD Assistant Professor of Neurological Surgery 525 E. 68th Street, Box 99 New York, NY 10021 Phone:212-746-1996 Fax: 212-746-8947 Click here to send an email Website: www.cornellneurosurgery.org/braintumor

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By